BARNES-JEWISH HOSPITAL
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
About Us
News & Events
Maps & Locations
Contact Us
Google Search
PATIENT AND VISITOR INFORMATION
TREATMENT PROGRAMS
PREVENTION AND SCREENING
RESEARCH
HOW TO HELP
FOR HEALTH PROFESSIONALS
Go back to:
Home
Treatment Programs
Types of Cancer
Clinical Trial Search Results
Share
Lymphoma
NCI Information
Clinical Trials
Non-Hodgkin Lymphoma Trials
Hodgkin Lymphoma Trials
Bone Marrow Transplant (BMT) Trials
Support Groups
Effects of Treatment
Patient Stories
Bone Marrow and Stem Cell Transplantation
Treatment Team
NEW SEARCH
RETURN TO SEARCH RESULTS
Number:
201210128
Principal Investigator:
Bartlett, Nancy
Title:
A Randomized, Open-label, Phase 3 Trial of A+AVD Versus ABVD as Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma (C25003)
Phase:
III
Disease Site:
Hodgkin's Lymphoma
Participating Site(s):
Main Campus
Map and Directions
St. Peters
Map and Directions
Contact:
800-600-3606 or
info@ccadmin.wustl.edu
Description:
The purpose of this research study is to compare how well two different treatments work. In this study, patients will receive either a treatment that includes the investigational drug called brentuximab vedotin or a commonly prescribed treatment that does not contain brentuximab vedotin.
More Information:
(Links will take you off this web site)
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)